| 000 | 01913cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030632.0 | ||
| 008 | 120611s2012 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.13.Ph.D.2012.Da.C | ||
| 100 | 0 | _aDalia Abdelwahab Hassan | |
| 245 | 1 | 0 |
_aCorrelation of tramadol blood level with clinical picture of intoxicated patient of poison control center / _cDalia Abdelwahab Hassan ; Supervised Fatma Abdelhamed , Mohy Kadry Elmasry , Amani Mahmoud Ahmed |
| 246 | 1 | 5 | _aالعلاقة المتناظرة بين نسبة مادة الترمادول في الدم و أعراض التسمم الخاصة بالشخص المصاب في مركز السموم الأكلينيكي |
| 260 |
_aCairo : _bDalia Abdelwahab Hassan , _c2012 |
||
| 300 |
_a141 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Forensic Medicine-Toxicology | ||
| 520 | _aTramadol is rapidly and almost completely absorbed and peaks 2 hours after administration. It is contraindicated in patients with past or present histories of opioid dependence. Toxic effect included lethargy, tachycardia, agitation, seizures, hypertension, and coma. Therapeutic use of tramadol may cause seizures, particularly on the first day after initiating therapy. Tramadol-related deaths have occurred both when it was used with other drugs and when it was used alone | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCorrelation | |
| 653 | 4 | _aToxic effect | |
| 653 | 4 | _aTramadol blood level | |
| 700 | 0 |
_aAmani Mahmoud Ahmed , _eSupervisor |
|
| 700 | 0 |
_aFatma Abdelhamed , _eSupervisor |
|
| 700 | 0 |
_aMohy Kadry Elmasry , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c38829 _d38829 |
||